You are viewing an incomplete version of our website. Please click to reload the website as full version.

Interleukin 31 (IL31) (N-Term) Peptide

Details for Product No. ABIN1382341, Supplier: Log in to see
Protein Name
  • 1700013B14Rik
  • IL-31
  • IL31
Protein Region
Mouse (Murine)
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-Interleukin 31 (IL31) (N-Term) antibody (ABIN1031414)
Characteristics 16 amino acids near the amino terminus of mouse IL31.
Application Notes IL-31 peptide is used for blocking the activity of IL-31.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Dillon, Sprecher, Hammond, Bilsborough, Rosenfeld-Franklin, Presnell, Haugen, Maurer, Harder, Johnston, Bort, Mudri, Kuijper, Bukowski, Shea, Dong, Dasovich, Grant, Lockwood, Levin, LeCiel, Waggie et al.: "Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. ..." in: Nature immunology, Vol. 5, Issue 7, pp. 752-60, 2004 (PubMed).

Schamel, Kuppig, Becker, Gimborn, Hauri, Reth: "A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 17, pp. 9861-6, 2003 (PubMed).